IP protection: India among most challenging economies, says USTR
India remains one of the most challenging major economies with respect to protection and enforcement of intellectual property, the office of the US Trade Representative said in a report as it decided to retain New Delhi on the Priority Watch List.
India remains one of the most challenging major economies with respect to protection and enforcement of intellectual property, the office of the US Trade Representative said in a report as it decided to retain New Delhi on the Priority Watch List.
In its 2022 Special 301 Report, the USTR designated seven countries in the Priority Watch List. These are Argentina, Chile, China, India, Indonesia, Russia and Venezuela.
The review of Ukraine has been suspended due to Russia's premeditated and unprovoked invasion of the country, the USTR said.
The USTR in the India section of the report said over the past year, India has remained inconsistent in its progress on IP protection and enforcement.
While India made meaningful progress to promote IP protection and enforcement in some areas over the past year, it failed to resolve recent and long-standing challenges and it created new concerns for right holders, the report said.
"India remains one of the world's most challenging major economies with respect to protection and enforcement of IP," it said.
The report further said India's accession to the World Intellectual Property Organization (WIPO) Performances and Phonograms Treaty and WIPO Copyright Treaty, collectively known as the WIPO Internet Treaties, in 2018 and the Nice Agreement in 2019 were positive steps.
However, the USTR said the potential threat of patent revocations, lack of presumption of patent validity and narrow patentability criteria under the Indian Patents Act impact companies across different sectors.
The USTR said despite India's justifications of limiting IP protections as a way to promote access to technologies, India maintains high customs duties on IP-intensive products such as medical devices, pharmaceuticals, information and communications technology products, solar energy equipment and capital goods.
In the pharmaceutical sector, the United States continues to monitor the restriction on patent-eligible subject matter in Section 3(d) of the Indian Patents Act and its impacts, it said.
Pharmaceutical stakeholders also express concerns as to whether India has an effective mechanism for the early resolution of potential patent disputes, particularly shortcomings in notifying interested parties of marketing approvals, it said.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000
IRCTC Dividend 2024: Railway PSU announces 200% interim dividend - Check record date and other details
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here
Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?
08:50 AM IST